CJ Wellcare Enhances Probiotic Development at IHMC 2026
CJ Wellcare unveiled innovative findings on a strain characteristic-based formula design technology during the 11th Congress of the International Human Microbiome Consortium (IHMC 2026), held in Seoul, South Korea from June 3 to June 5. This new technology aims to maximize the viability and functional activity of lactic acid bacteria.
Key Findings
The firm emphasized the unique nutritional requirements of various probiotic strains, specifically their varying prebiotic needs. Through extensive research, CJ Wellcare focused on optimized synbiotics tailored to these distinct characteristics. A notable study highlighted the analysis of multiple Lactiplantibacillus plantarum strains, particularly their patented strain CJLP133.
- Growth Performance:
- CJLP133 exhibited a growth increase of up to 200 times in a specific oligosaccharide (GOS) environment compared to general glucose conditions.
- Contrarily, growth responses varied significantly among strains in different prebiotic environments, indicating that optimal combinations depend on each strain’s unique traits.
The company aims to leverage this genome analysis-based technology in developing next-generation products for its premium probiotic brand, BYOCORE.
Statement from CJ Wellcare
A representative from CJ Wellcare stated, “This research demonstrates the potential to enhance the efficacy of CJLP133, leveraging our unique microbiome R&D capabilities to strengthen BYOCORE’s competitiveness and reliability in wellness solutions.”
Innovating Sleep Management Solutions
In a strategic move towards enhancing sleep health, CJ Wellcare has partnered with CirKadian, a sleep tech start-up. They signed a Memorandum of Understanding (MOU) to develop personalized solutions that utilize data on sleep and circadian rhythms.
Objectives of the Partnership
-
Joint Research Projects: The collaboration will focus on integrating both companies’ R&D and technological strengths.
-
Algorithm Development: The aim is to create an algorithm that analyzes individual sleep patterns, daily cycles, and monitors melatonin secretion, using CirKadian’s circadian rhythm technologies.
-
Integration with Devices: Future plans include the capability to connect with hardware like CirKadian’s Mellight lamp.
Future Goals
CJ Wellcare intends to lead the research and commercialization of sleep and melatonin-related functional products while managing distribution. Ultimately, the goal is to offer personalized sleep health solutions, optimizing melatonin intake based on comprehensive sleep and environmental data.
In conclusion, CJ Wellcare is positioning itself at the forefront of health product innovation by integrating advanced scientific research with consumer wellness strategies, marking a significant step toward enhanced probiotic efficacy and sleep health management.
